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Background: So-Cheong-Ryong-Tang (SCRT), a traditional Korean medicine containing eight species of medicinal
plant, has been used to treat patients with bronchial asthma and allergic rhinitis for hundreds of years; however, its
anti-cancer potential is poorly understood. The present study was designed to evaluate the apoptotic effect of SCRT
against human non-small-cell lung cancer (NSCLC) A549 cells.
Methods: The effects of SCRT on cell growth and viability were evaluated by trypan blue dye exclusion and
3-(4, 5-dimethyl-thiazol-2-yl)-2, 5-diphenyl tetrazoliumbromide (MTT) assays, respectively. Apoptosis was detected
using 4,6-diamidino-2-phenyllindile (DAPI) staining, agarose gel electrophoresis and flow cytometry. The protein
levels were determined by Western blot analysis. Caspase activity was measured using a colorimetric assay.
Results: SCRT treatment resulted in significantly decreased A549 cell growth and viability by induction of apoptosis.
SCRT induced the translocation of pro-apoptotic Bax to the mitochondria, mitochondrial membrane
permeabilization, cytochrome c release from mitochondria to cytosol, and activated caspase-9 and caspase-3. SCRT
also increased death receptor-associated ligands and enhanced the activation of caspase-8 and cleavage of its
substrate Bid. However, the pan-caspases inhibitor significantly blocked the SCRT-induced apoptosis, suggesting that
it is a caspase-dependent pathway. In addition, SCRT suppressed the phosphorylation of phosphoinositide 3-kinase
(PI3K) and Akt, and treatment with a potent inhibitor of PI3K further increased the apoptotic activity of SCRT.
Conclusions: These findings suggest that SCRT may play its anti-cancer actions partly through a suppression of the
PI3K/Akt signal pathway in A549 cells, and further in vivo studies on the potential of SCRT for prevention and
therapy of NSCLCs are warranted.
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Non-small-cell lung cancer (NSCLC), accounting for
about 80% of human lung cancers, is one of the leading
causes of cancer deaths worldwide. Therapeutic strat-
egies for lung cancer treatment include surgery, radio-
therapy, chemotherapy, and targeted and combined
therapies. Despite advances in treatment, the poor prog-
nosis is largely attributable to the inherent or acquired
resistance in cancer cells against conventional chemo-
therapy [1,2]. Although, many studies have reported po-
tential chemotherapeutic effects of novel compounds,
novel agents with proven efficacy and minimal toxicity
are urgently required for the treatment of NSCLC.
The progression of cancer is characteristically linked
to a resistance to apoptosis, a major type of cell death
that occurs when DNA damage is irreversible. Apoptosis
is characterized by distinct morphological and biochem-
ical changes such as cell shrinkage, membrane blebbing,
chromatin condensation, activation of proteases, and
externalization of phosphatidylserine [3,4]. Therefore,
agents targeting the apoptosis pathway without affecting
normal cells play crucial roles as potential drug targets
in cancer treatment. In mammalian cells, apoptosis may
be initiated in two ways, via an intrinsic (mitochondrial-
mediated) or extrinsic (death receptor (DR)-mediated)
pathway that involves the activation of caspases [5,6].
The former is activated by the release of pro-apoptotic
factors such as cytochrome c from the mitochondrial
matrix following the loss of inner mitochondrial mem-
brane integrity and activation of caspase-9. The latter is
initiated by the binding of extracellular death ligands to
their cell-surface death receptors leading to the activa-
tion of caspase-8. The extrinsic pathway can crosstalk to
the intrinsic pathway through the caspase-8-mediated
cleavage of Bid, a member of the Bcl-2 family of pro-
teins, which ultimately leads to apoptosis [7,8].
For thousands of years, herbal medicines have been
used seemingly safely and effectively to treat and allevi-
ate various diseases in Asia, including Korea, China, and
Japan. Recently, there has been increasing interest in the
pharmacological activity of traditional medicines, and
numerous studies support their potential clinical benefit
for diseases that are difficult to treat [9,10]. Typical trad-
itional Korean medicines derived from ancient Chinese
herbal medicines and consist of at least four 4 components
that are mixed to minimize side effects, maximize medical
effects, and improve the patient’s quality of life. So-
Cheong-Ryong-Tang (SCRT), also known as Xiao-Qing-
Long-Tang in China and Sho-Seiru-To in Japan, is an
aqueous polyherbal formulation, consisting of eight spe-
cies of medicinal herb. SCRT has been used to treat bron-
chial asthma and allergic rhinitis for hundreds of years in
Asian countries [11]. Studies regarding its pharmaco-
logical action have shown an inhibition of histaminerelease and degranulation of mast cells [12], reduced
serum IgE level in allergic rhinitis patients [13,14], de-
creased allergen-induced bronchial inflammation [15], the
growth and differentiation of basophils [16] and passive
cutaneous anaphylaxis [17]. Recently, Byun et al. [18]
demonstrated that SCRT improved the quality of life and
reduced the symptoms of illness in common cold patients,
and it was also found that SCRT exhibits immunomodula-
tive and anti-inflammatory activities [19-21]. However,
despite its valuable effects, little is known about the anti-
cancer potential of SCRT. In this study, as a part of our
search for novel biologically active substances for the pre-
vention and treatment of cancer from traditional Korean
medicine we evaluated whether SCRT could inhibit cell
growth and trigger apoptosis in NSCLC A549 cells.
Methods
Reagents and antibodies
Dulbecco’s modified eagle’s medium (DMEM), fetal bo-
vine serum (FBS), penicillin, streptomycin, and trypsine-
ethylene diamine tetraacetic acid (EDTA) were pur-
chased from Gibco-BRL (Gaithersburg, MD, USA). 3-
(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium
bromide (MTT), 4,6-diamidino-2-phenyllindile (DAPI),
phenol:chloroform:isoamylalcohol, ethidium bromide
(EtBr), RNase A, dithiothreitol (DTT), bovine serum
albumin (BSA), propidium iodide (PI), paraformalde-
hyde and 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethyl-imi-
dacarbocyanine iodide (JC-1) were purchased from
Sigma-Aldrich Chemicals (St. Louis, MO, USA). N-benzy-
loxycarbonyl-Val-Ala-Asp-fluoromethylketone (z-VAD-
fmk), a pan-caspase inhibitor, and LY294002, a selective
inhibitor of phosphatidylinositol 3-kinase (PI3K), were ob-
tained from Calbiochem (San Diego, CA, USA) and Cell
Signaling Technology, Inc. (Danvers, MA, USA), respect-
ively. Annexin V-fluorescein isothiocyanate (FITC) and
caspase activity assay kits were purchased from R&D Sys-
tems (Minneapolis, MN, USA). DNA ladder size marker
and enhanced chemiluminescence (ECL) kit were pur-
chased from Invitrogen (Carlsbad, CA, USA) and Amer-
sham Corp. (Arlington Heights, IL, USA), respectively. A
mitochondrial fractionation kit was obtained from Active
Motif (Carlsbad, CA, USA). Primary antibodies were pur-
chased from Santa Cruz Biotechnology (Santa Cruz,
CA, USA), Chemicon (Temecula, CA, USA) and Sigma-
Aldrich. Peroxidase-labelled donkey anti-rabbit and
sheep anti-mouse immunoglobulin were purchased
from Amersham. All other chemicals not specifically
mentioned here were purchased from Sigma-Aldrich.
Preparation of SCRT extract
SCRT, containing eight species of medicinal plant
(Table 1), was obtained from Dongeui Oriental Hospital
at the Dongeui University College of Korean Medicine






Ephedra sinica Stadf. (Ephedrae Herba) 6.0 (14.3)
Paeonia lactiflora Pall. (Paeoniae Radix) 6.0 (14.3)
Schizandra chinensis (Turcz.) Ball. (Schizandrae Fructus) 6.0 (14.3)
Pinellia ternata (Tenore et Breit. (Pinelliae Rhizoma) 6.0 (14.3)
Asiarum sieboldii F. Maekawa (Asiasari Radix) 4.0 (9.5)
Zingiber officinale Rosc. (Zingiberis Rhizoma) 4.0 (9.5)
Cinnamomum cassia Blume. (Cinnamomi Ramulus) 4.0 (9.5)
Glycyrrhiza glabra L. (Glycyrrhizae Radix) 4.0 (9.5)
Total amounts 40 (100)
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thenticated by Professor Su Hyun Hong, Department of
Biochemistry, Dongeui University College of Korean
Medicine. Each herb in SCRT was cut into small pieces,
ground to a fine powder, passed through a 20-mesh
sieve, and then mixed with the others to yield at total
sample of 40 g in the ratios in shown Table 1. The mix-
ture was extracted with 500 ml of boiling water for six
hours. The extracted liquid was filtered twice to remove
insoluble materials. The filtered liquid was lyophilized
and then crushed into a thin powder. The yield of dried
extract from starting crude material was 9.72 g (24.3%,
w/w). The extracts were resuspended in distilled water
to a final concentration of 100 mg/ml (extract stock so-
lution), and then diluted with media to the desired con-
centration prior to use. The voucher specimens (accession
number DEU-30) have been deposited at a publicly avail-
able Natural Resource Bank of Dongeui University College
of Oriental Medicine.
Cell culture
The human NSCLC A549 cells and WI-38 human fetal
lung fibroblasts were purchased from the American Type
Culture Collection (Manassas, VA, USA) and maintained
in DMEM supplemented with 10% FBS, 1% L-glutamine
and penicillin/streptomycin. The cells were cultured in an
incubator with 5% CO2 at 37°C.
Cell growth and cell viability assay
Cell growth was assessed using the trypan blue dye ex-
clusion assay. In brief, cells (2 × 104 cells/well) were
seeded in 6-well plates. After treatment with the indi-
cated concentrations of the SCRT for the indicated
times, the cells were trypsinized and viable cells were
counted by trypan blue dye exclusion using a
hemocytometer under an inverted microscope (Carl
Zeiss, Jena, Germany). Cell viability was determined
using the MTT assay. In brief, cells (2 × 104 cells/well)were seeded in 24-well plates and exposed to the ex-
tracts of SCRT for the indicated times. After treatment,
5 mg/ml MTT solution was added, followed by 3 h in-
cubation at 37°C in the dark, and the media was then
removed. The formazan precipitate was dissolved in di-
methyl sulfoxide, and absorbance of the formazan
product was measured at a wavelength of 540 nm with an
enzyme-linked immunosorbent assay (ELISA) reader
(Molecular Devices, Sunnyvale, CA, USA). For the mor-
phological study, cells were photographed directly using an
inverted microscope (Carl Zeiss, Oberkochen, Germany).
Nuclear staining with DAPI
For the assessment of apoptosis, morphological changes
of nuclei were visualized following DNA staining by the
fluorescent dye, DAPI. The cells were fixed with 3.7%
paraformaldehyde for 20 min at room temperature and
washed with phosphate-buffered saline (PBS). Cells were
then stained with 2.5 μg/ml DAPI solution for 10 min at
room temperature. The cells were washed twice with
PBS and stained nuclei were observed using a fluores-
cence microscope (Carl Zeiss).
DNA fragmentation assay
After treatment with SCRT, cells were lysed in a buffer
containing 10 mM Tris (pH 7.4), 150 mM NaCl, 5 mM
EDTA and 0.5% Triton X-100 for 30 min on ice. Lysates
were vortexed and cleared by 19,000 g centrifugation for
30 min at 4°C. Fragmented DNA in the supernatant was
extracted with an equal volume of neutral phenol:
chloroform:isoamylalcohol (25:24:1, v/v/v), followed by
electrophoretic analysis on 1.5% agarose gels containing
0.1 μg/ml EtBr.
Flow cytometric detection of apoptosis
To analyze cell cycle profiles, cells were harvested,
washed twice with ice-cold PBS, fixed with 75% ethanol
at 4°C for 30 min, and washed in PBS with 0.1% BSA.
The cells were then incubated with 1 U/ml of RNase A
(DNase free) and 10 μg/ml of PI overnight at room
temperature in the dark. Cells were analyzed using a
FACSCalibur flow cytometer (Becton Dickenson; San
Jose, CA). The level of apoptotic cells containing sub-G1
DNA content was determined as a percentage of the
total number of cells. The cells were also stained with 5
μl of annexin V-FITC and 5 μl of PI in each sample.
After at 15 min incubation at room temperature in the
dark, the degree of apoptosis was quantified as a per-
centage of the Annexin V-positive and PI-negative
(annexin V+/PI− cells) cells by a flow cytometer [22].
Western blot analysis
Cells were harvested and lysed with lysis buffer (20 mM
sucrose, 1 mM EDTA, 20 μM Tris-Cl, pH 7.2, 1 mM
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nin) for 30 min at 4°C. The mixtures were centrifuged at
12,000 g for 10 min at 4°C, and the supernatants were
collected as whole-cell extracts. In a parallel experiment,
the mitochondrial and cytosolic fractions were isolated
using a mitochondrial fractionation kit according to the
manufacturer’s instructions. The protein content was
determined using the Bio-Rad protein assay reagent
(Bio-Rad, Hercules, CA, USA) and BSA as a standard
according to the manufacturer’s instructions. Equal
amounts of protein were separated electrophoretically
using sodium dodecyl sulfate (SDS)-polyacrylamide gels
transferred to nitrocellulose membranes (Amersham).
The membranes were soaked in blocking buffer (5%
skimmed milk) and incubated overnight with primary
antibodies followed by horseradish peroxidase conju-
gated antibodies at room temperature. Detection of spe-
cific proteins was carried out with an ECL Western
blotting kit according to the manufacturer’s instructions.Determination of caspase activity
The activity of caspase-like protease was measured using
a caspase activation kit according to manufacturer’s
protocol. The kits utilize synthetic tetrapeptides labeled
with p-nitroanilide (pNA) linked to the end of the
caspase-specific substrate. To evaluate caspase activity,
cell lysates were prepared after treatment with SCRT
and incubated with the supplied reaction buffer and the
colorimetric substrates at 37°C for 2 h in the dark. The
cleavage of the peptide by the caspase releases the
chromophore pNA, which can be quantified spectro-
photometrically at a wavelength of 405 nm using an
ELISA reader.Measurement of mitochondrial membrane potential
(MMP, Δψm)
The values of MMP were determined using the dual-
emission potential-sensitive probe, JC-1, which is internal-
ized and concentrated by respiring mitochondria and can
therefore reflect changes in MMP in live cells. Cells were
collected and incubated with 10 μM of JC-1 for 30 min at
37°C in the dark. After the JC-1 was removed, the cells
were washed with PBS to remove any unbound dye and the
amount of JC-1 retained by 10,000 cells per sample was
measured at 488 nm and 575 nm using a flow cytometer.Statistical analysis
The data are reported as the mean ± standard deviation
(SD) of three independent experiments. A one-way
ANOVA was performed to determine statistical signifi-
cance. Significant differences were established at p <0.05.Results
Effects of SCRT on A549 cell growth and viability
To examine the effect of SCRT on the cell growth and
viability of A549 cells, cells were treated with various
concentrations of SCRT for the indicated times and the
assay, and then the trypan blue dye exclusion and MTT
assays were performed. Our data indicated that SCRT ex-
hibited cytotoxic effects in a dose- and time-dependent
manner (Figure 1A and B), which was associated with sig-
nificant morphological changes, including extensive cyto-
solic vacuolization and the appearance of irregular cell
membrane buds (Figure 1D). However, the presence of
SCRT did not inhibit the cell viability of WI-38 cells sig-
nificantly (Figure 1C), indicating that SCRT has not cyto-
toxic effect to the normal lung fibroblast. We next
examined the DAPI staining to determine whether the
cytotoxic effect of SCRT was mediated by apoptosis. As
shown in Figure 2A, when the SCRT concentration in-
creased, more and more cells exhibited the morphological
characteristics of apoptosis, such as chromatin condensa-
tion and apoptotic body formation. In addition to cell
morphology, the fragmentation of chromatin into units of
single or multiple nucleosomes was also examined with
using agarose gel electrophoresis to observe the DNA lad-
der formation. As shown in Figure 2B, there was no evi-
dence of oligonucleosomal DNA ladder in the control
group; however, the DNA ladder became more evident in
the SCRT groups in a dose-dependent fashion, indicating
an increasing amount of apoptotic cells.
To measure apoptotic cell death upon SCRT treat-
ment, we stained cells with PI and cycle profiles were
analyzed using a flow cytometer. The results after PI
staining showed that SCRT increased the percentage of
cells in the apoptotic hypodiploid sub-G1 phase in a
dose-dependent manner (Figure 2C). Annexin V-FITC/
PI double staining was also performed to assess the rate
of apoptotic cell death, and a significant degree of apop-
tosis was detected in the SCRT-treated A549 cells, as
shown by an increased phosphatidyl exposure using
annexin V-FITC (Figure 2D). The results we obtained
corresponded very well with our cell morphology obser-
vations and DNA fragmentation analysis, indicating the
cytotoxic effects observed in response to SCRT are asso-
ciated with the induction of apoptosis in A549 cells.
Activation of caspases by SCRT in A549 cells
The activation of caspases plays a very important role in
apoptosis, and the activation of individual caspases is
can either be an autocatalytic process or triggered by
other members of the caspase family in a cascade fash-
ion. Among several caspases, caspase-3 is downstream
of both the extrinsic and intrinsic pathways, which in-
clude caspase-8 and −9 [4,5,8]. Therefore, we investi-
gated whether SCRT activated any of these pathways
Figure 1 SCRT inhibits cell viability and induces morphological changes in A549 cells. (A, B and C) A549 and WI-38 cells were treated
with various concentrations of SCRT for the indicated times. The cell viability was measured by the trypan blue exclusion method (A) and the
metabolic-dye-based MTT assay (B and C). Each point represents the mean ± SD of three independent experiments. The significance was
determined by the Student’s t-test (*p < 0.05 vs. untreated control). (D) Cells were treated with the indicated concentrations of SCRT for 72 h
and photographed under an inverted microscope (original magnification 200x).
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activity assay. Although the active forms of caspases-8
and −9 were not observed, levels of the pro-forms of
caspase-8, and −9, initiator caspases of extrinsic and in-
trinsic apoptosis pathways, respectively, were down-
regulated while their in vitro activities were significantly
increased in SCRT-treated A549 cells in a dose-
dependent manner. These activities were accompanied
by the activation of caspase-3 and the cleavage of poly
(ADP-ribose) polymerase (PARP) and phospholipase C
(PLC)-γ1, intracellular substrates for activated caspase-3
[23,24] (Figure 3A and B). These results indicated that
SCRT activates initiator and executioner caspases in-
volved in both the extrinsic and the intrinsic pathways.
In addition, SCRT treatment down-regulated or cleaved
the proteins of inhibitor of the apoptosis proteins (IAP)
family, such as anti-X-linked inhibitor of apoptosis pro-
tein (XIAP), cellular inhibitor of apoptosis (cIAP)-1,
cIAP-2 and survivin (Figure 3C), which bind to caspases
and lead to their inactivation [25,26], indicating thatSCRT-induced activation of caspases was associated with
the reduction of IAP family proteins in A549 cells.
To confirm caspase activation’s role in SCRT-induced
apoptosis, cells were pre-incubated with a pan-caspase in-
hibitor, z-VAD-fmk, for 1 h and then treated with SCRT.
As shown in Figure 4A and B, pre-treatment of A549 cells
with z-VAD-fmk significantly inhibited apoptotic body for-
mation, nuclear shrinkage, and DNA fragmentation follow-
ing treatment with SCRT. Furthermore, z-VAD-fmk also
decreased the accumulation of annexin V-FITC stained
cells and increased cell viability in SCRT-treated A549 cells
(Figure 4C and D), indicating that SCRT induces caspase-
dependent apoptosis in A549 cells.
Mitochondrial translocation of Bax and loss of MMP by
SCRT in A549 cells
The intrinsic apoptosis pathway is dependent on the re-
lease of apoptotic factors such as cytochrome c from the
mitochondria to the cytosol, which is believed to be an
initiator of the caspase cascade. Releasing apoptotic
Figure 2 SCRT induces apoptosis in A549 cells. (A) Cells were treated with the indicated concentrations of SCRT for 72 h, fixed, and stained
with DAPI solution. The stained nuclei were observed under a fluorescent microscope (original magnification 400x). (B) For the analysis of DNA
fragmentation, genomic DNA from cells grown under the same conditions as (A) was extracted, separated by 1.5% agarose gel electrophoresis,
and visualized under UV light after staining with EtBr. The DNA marker indicates the size of the fragments of the DNA ladder. (C) To quantify the
degree of apoptosis induced by SCRT, cells were evaluated by a flow cytometer for sub-G1 DNA content, which represents the cells undergoing
apoptotic DNA degradation. (D) The cells were stained with annexin V-FITC and PI, and the percentages of apoptotic cells (annexin V+ cells) were
then analyzed using flow cytometric analysis. (C and D) The data is the mean of the two different experiments.
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family, which is composed of pro- and anti-apoptotic
proteins [6,27]. To confirm whether the intrinsic path-
way is involved in SCRT-induced apoptosis, the effect of
SCRT on the levels of anti-apoptotic Bcl-2, pro-
apoptotic protein Bax and cytochrome c was monitored.As shown in Figure 5A, the total levels of Bax and Bcl-2
proteins remained unchanged in response to SCRT treat-
ment. However, SCRT treatment decreased cytosolic levels
of Bax, while its mitochondrial levels significantly in-
creased after treatment with SCRT in a dose-dependent
manner (Figure 5B). Cytochrome c was also tested in
Figure 3 Activation of caspases, degradation of PARP and PLC-γ1, and down-regulation of the IAP family proteins by SCRT in A549
cells. (A and C) Cells were treated with the indicated concentrations of SCRT for 72 h. The cells were lysed, and the cellular proteins were
visualized using the indicated antibodies and an ECL detection system. Actin was used as an internal control. The experiment was repeated three
times and similar results were obtained. The relative ratios of expression in the results of the Western blotting were presented at the bottom of
each of the results as relative values of the actin expression. (B) After 72 h incubation with the indicated concentrations of SCRT, the cells were
lysed, and aliquots (50 μg protein) were assayed for in vitro caspase-3, −8 and −9 activity using DEVD-pNA, IETD-pNA and LEHD-pNA as substrates,
respectively, at 37°C for 1 h. The released fluorescent products were measured. The data are expressed as the mean ± SD of three independent
experiments. The significance was determined by the Student’s t-test (*p < 0.05 vs. untreated control).
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Figure 5B. SCRT treatment caused a marked decrease in
mitochondrial cytochrome c and a concurrent increase in
cytosolic cytochrome c (Figure 5B).
The release of cytochrome c often involves changes
in MMP, and the loss of MMP in cells is one of the
early critical events in the intrinsic apoptosis pathway,
eventually causing the initiation and activation of
apoptotic cascades [28,29]. Therefore, we sought to de-
termine whether SCRT treatment had any effect on theMMP in A549 cells using fluorescent dye JC-1 staining.
Figure 5C shows that treatment of A549 cells with
SCRT resulted in a dose-dependent increase in the
proportion of green fluorescence-positive cells (indi-
cating a loss of mitochondrial membrane potential),
confirming that SCRT induced the loss of MMP. These
results indicated that SCRT could induce the mitochon-
drial translocation of Bax and loss of MMP resulting in
mitochondrial dysfunction, release of cytochrome c to the
cytosol, and ultimately, apoptosis induction.
Figure 4 Pan-caspase inhibitor z-VAD-fmk alleviates SCRT-induced apoptosis in A549 cells. (A) Cells were incubated with 1.5 mg/ml of
SCRT for 72 h after 1 h pretreatment with z-VAD-fmk (50 μM). After staining with DAPI solution, the nuclei were observed under a fluorescent
microscope (original magnification 400x). (B) The genomic DNA from cells was extracted, separated by agarose gel electrophoresis, and visualized
under UV light after staining with EtBr. (C) The percentages of apoptotic cells (annexin V+ cells) were analyzed using flow cytometric analysis. The
data is the mean of the two different experiments. (D) Cell viability was determined by MTT assays. Each point represents the mean ± SD of three
independent experiments. The significance was determined using Student’s t-test (*p < 0.05 vs. untreated control; #p < 0.05 vs.
SCRT-treated cells).
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(DR)-related proteins and Bid by SCRT in A549 cells
The extrinsic apoptosis pathway begins outside the cell
by the binding of death-inducing ligands to their suitable
DRs on the cell surface. This is followed by receptor
clustering and transmission of the intracellular signals
that ultimately result in the destruction of the cell
through the activation of caspase-8. Caspase-8 can then
activate caspase-3 and cleave Bid, a specific substrate for
caspase-8, to form truncated Bid (tBid). Once Bid is
cleaved by caspase-8, the tBid translocates to the mito-
chondrial membrane and enhances cytochrome c re-
lease, amplifying the mitochondrial-mediated intrinsic
pathway [30,31]. Thus, we further investigated whether
SCRT affects the extrinsic pathway by analyzing theeffects of SCRT on the DR-related proteins and Bid ex-
pression. As demonstrated in Figure 6, after SCRT treat-
ment, the levels of DR4, DR5 and Fas were not altered;
however, the expression of tumour necrosis factor
(TNF)-related apoptosis inducing ligand (TRAIL) and as
well as Fas ligand (FasL) strongly increased in a dose-
dependent manner. Subsequent Western blot analysis
revealed that progressive down-regulation of total Bid
protein and accumulation of tBid (Figure 6), presumably
resulting from a truncation by caspase-8, occurred in
A549 cells treated with SCRT. The results indicate that
cytotoxic effects induced by SCRT could be mediated
through the DR-mediated apoptosis, thereby accentuat-
ing the crosstalk between the intrinsic and extrinsic
apoptosis pathways.
Figure 5 Effects of SCRT on the expression of Bcl-2, Bax and cytochrome c, and values of MMP in A549 cells. (A) Cells were treated with
SCRT for 72 h, and aliquots containing total proteins were subjected to SDS-polyacrylamide gels followed by immunoblot analysis with specific
antibodies. (B) The cytosolic and mitochondrial proteins were extracted from cells and analyzed by Western blotting using the indicated antibodies.
Actin and cytochrome oxidase IV (COX IV) were used as internal controls for the cytosolic and mitochondrial fractions, respectively. The relative ratios of
expression in the results of the Western blotting were presented at the bottom of each of the results as relative values of the actin or COX IV or
expression. (C) The cells were collected and incubated with JC-1 (10 μM) for 20 min at 37°C in the dark. The cells were then washed once with PBS
and analyzed by a flow cytometer. The data is expressed as the mean of two independent experiments.
Park et al. BMC Complementary and Alternative Medicine  (2015) 15:113 Page 9 of 13Effects of SCRT on the PI3K/Akt pathway in A549 cells
The PI3K/Akt pathway is one of the most important sig-
naling networks in cell growth and the survival of many
cancers [32,33]. To determine the role of SCRT in the
PI3K/Akt pathway, we investigated the expression andphosphorylation levels of PI3K and Akt, a downstream
effector of PI3K, in A549 cells after treatment with
SCRT. As shown in Figure 7A, the phosphorylation levels
of PI3K and Akt significantly decreased after SCRT treat-
ment in a time-dependent manner. However, expression
Figure 6 Effects of SCRT on the expression of DR-related
proteins and Bid in A549 cells. Cells were treated with the
indicated concentrations of SCRT for 72 h. The cells were lysed, and
the cellular proteins were visualized using the indicated antibodies
and an ECL detection system. Actin was used as an internal control.
The experiment was repeated three times and similar results were
obtained. The relative ratios of expression in the results of the
Western blotting were presented at the bottom of each of the
results as relative values of the actin expression.
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throughout the experiment. To address the possible role
of cell viability as a modulation of PI3K/Akt pathway in
SCRT-induced apoptosis in A549 cells, we used the PI3K
inhibitor, LY294002, for further studies. As shown in
Figure 7B-D, treatment of LY294002 markedly increased
SCRT-induced apoptosis as demonstrated by nuclear
morphology, DNA fragmentation, and annexin V-FITC
staining. These results strongly demonstrate that the in-
activation of PI3K/Akt signaling pathway is involved in
SCRT-induced A549 cell apoptosis.
Discussion
In the present study, we investigated the effects of SCRT
on NSCLC A549 cells and demonstrated that SCRT in-
hibits A549 cell growth, an effect correlated with apop-
tosis induction. In our study, chromatin condensation of
the nuclei, DNA fragmentation, and an increase of sub-G1 phase, and annexin V-FITC-stained cells demon-
strated the apoptosis induction (Figures 1 and 2). We
then examined various aspects of the mechanisms of
apoptosis induction by SCRT in A549 cells and found
SCRT-activated caspase-9 -8, and −3, which are associ-
ated with the loss of MMP and degradation of PARP
and PLC-γ1. SCRT also down-regulated IAP family pro-
teins, which reportedly block apoptosis directly by binding
to and inhibiting several caspases (Figure 3). However,
blocking caspase activity by pretreating the cells with a
pan-caspase inhibitor significantly prevented SCRT-
induced apoptosis and growth inhibition (Figure 4).
Therefore, the data support a finding that SCRT-
induced apoptosis in A549 cells is caspase-dependent,
and both the intrinsic and the extrinsic pathways are ac-
tivated by SCRT.
Apoptosis, as a programmed cell death, is a rigorous,
active, and orderly process of cell death, regulated by nu-
merous gene products to maintain the stability of the
intracellular environment. Among them, cytochrome c is
a small heme protein found loosely associated with the
inner membrane of the mitochondrion. The release of
cytochrome c from the mitochondria into the cytoplasm
through an opening of the mitochondrial permeability
transition pore (MPTP) followed by a swelling-induced
rupture of the mitochondrial outer membrane is an im-
portant component in the intrinsic pathway. The protein
binds apoptotic protease activating factor-1 (Apaf-1) and
activates caspase-9 in the cytoplasm. Once initiated,
caspase-9 can go on to activate effector caspases such as
caspase-3 and −7, which then cleave many important
cellular substrates and causes cell death [5,34,35].
The Bcl-2 protein family is a major regulator of apop-
tosis, as the balance of pro-apoptotic and anti-apoptotic
Bcl-2 family proteins decide the fate of the cell. The pro-
teins are also important regulators of cytochrome c re-
lease from the mitochondria through the regulation of
MPT. For example, the pro-apoptotic protein Bax facili-
tates the openness of the MPTP and the subsequent
cytochrome c release, which in turn activates the caspase
cascade reaction, eventually resulting in apoptosis. Con-
versely, the anti-apoptotic protein Bcl-2 protects mito-
chondria against the loss of function during apoptosis by
inhibiting the MPTP’s opening, the Bcl-2-Apaf1-cas-
pase-9 complex, and apotosome, resulting in an anti-
apoptosis effect [34,35]. Interestingly, the present data
revealed that SCRT did not affect the total expression
levels of Bax as well as Bcl-2; however, SCRT treatment
resulted in a dose-dependent increase in mitochondrial
levels of Bax with a concomitant decrease in the cyto-
plasmic Bax levels. Our data also clearly showed that
SCRT treatment resulted in a dose-dependent increase
in the release of cytochrome c (Figure 5). Because the re-
lease of cytochrome c requires mitochondrial membrane
Figure 7 SCRT triggers apoptosis through an inactivation of PI3K/Akt signaling in A549 cells. (A) The cells were treated with SCRT (1.5
mg/ml) for the indicated times. Equal amounts of cell lysate were resolved by SDS-polyacrylamide gels, transferred to nitrocellulose membranes,
and probed with the anti-p-PI3K, anti-p-Akt, anti-PI3K and anti-Akt antibodies. The proteins were visualized using an ECL detection system. Actin
was used as an internal control. The relative ratios of expression in the results of the Western blotting were presented at the bottom of each
of the results as relative values of the actin expression. (B-D) The cells were pretreated with PI3K inhibitor (LY294002, 50 μM) for 1 h and then
treated with SCRT (1.5 mg/ml) for 72 h. (B) After staining with DAPI solution, the nuclei were observed under a fluorescent microscope (original
magnification 400x). (C) The genomic DNA from cells was extracted, separated by agarose gel electrophoresis, and visualized under UV light after
staining with EtBr. (D) The percentages of apoptotic cells (annexin V+ cells) were analyzed using flow cytometric analysis. The data is the mean of
the two different experiments.
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translocation of pro-apoptotic Bax proteins from the
cytosol to mitochondria represents a key event for the
activation of the intrinsic pathway. Therefore, our data
indicated that SCRT induces Bax translocation to mito-
chondria from the cytosol, leading to the release of cyto-
chrome c, apoptosome formation, and finally, induction
of apoptosis in A549 cells.
Our results also demonstrate that SCRT activates the
death receptor-mediated extrinsic pathway. The extrinsic
pathway can be triggered to undergo oligomerization
when proper ligands bind their respective death recep-
tors, ultimately recruiting adaptor molecules and
caspase-8 into a complex resulting in activated caspase-
8. In addition, caspase-8 connects to the intrinsic path-
way via cleavage of the Bcl-2 family member Bid to form
tBid. Under normal conditions, Bid is located in the
cytoplasm in an inactive state; however, tBid can trans-
locate the mitochondrial membrane where it interacts
with Bax proteins. This interaction promotes the fusionof Bax and the mitochondria, which results in changes
to the configuration of Bax proteins. These changes en-
hance mitochondrial dysfunction, resulting in the for-
mation of membrane pores and permitting the release
of cytochrome c to the cytosol, followed by the activa-
tion of caspase-9 [28,30]. This event leads to activation
of caspase-3 for the induction of apoptosis via a release
of cytochrome c to the cytosol [4,8]. Moreover, tBid
directly binds to Bcl-2 and thereby inhibits its anti-
apoptosis effect [30,31]. Although the levels of death re-
ceptors such as DR4, DR5, and Fas remained unchanged
in SCRT-treated A549 cells, SCRT notably increased the
levels of their ligands including TRAIL and FasL, while
a decline of intact Bid occurred concurrently with a
pronounced increase of tBid (Figure 6).
On the other hand, PI3K plays a critical role in cell sur-
vival and proliferation in collaboration with its major
downstream effector Akt. Notably, the aberrant activation
of the PI3K/Akt pathway is implicated in the initiation
and progression of several types of human malignancies,
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PI3K/Akt pathway is associated with resistance to chemo-
therapeutic agents [32,37]. Meanwhile, anti-apoptotic pro-
teins such as survivin and Bcl-2, and caspase-3 are the
downstream target of Akt, and are related to proliferation
and apoptosis [38,39]. Many previous studies also have in-
dicated that the pro-apoptotic potential of some anti-
cancer agents is highly correlated with the inactivation of
the PI3K/Akt pathway [33,40-43]. These observations in-
dicate that the inhibition of the PI3K/Akt signaling cas-
cade can serve as an effective strategy for the treatment of
cancers. In the present study, we further studied the pos-
sible role of the PI3K/Akt pathway in the SCRT-
induced apoptosis of A549 cells and found the levels of
phosphorylated PI3K and Akt, were markedly de-
creased after SCRT treatment (Figure 7A). The total
levels of PI3K and Akt were unchanged with SCRT
treatment. In addition, there was a significant increase
in apoptotic activity when A549 cells were treated with
a combination of SCRT and LY294002, a PI3K inhibi-
tor, whereas treatment with LY294002 alone did not
affect the growth of A549 cells (Figure 7B-D). This re-
sult provides another piece of evidence that SCRT can
induce apoptosis by reducing PI3K/Akt pathway acti-
vation in A549 cells.Conclusions
In conclusion, we described how SCRT significantly in-
hibits the growth of NSCLC A549 cells and induces cell
apoptosis in vitro. SCRT treatment increases the loss of
MMP and translocalization of Bax to the mitochondria,
and leads to cytochrome c release to the cytosol and ac-
tivation of caspase-9 and −3, resulting in the activation
of the intrinsic apoptosis pathway. SCRT also activates
the extrinsic apoptosis pathway by increasing both
TRAIL and FasL, resulting in the activation of caspase-8
and Bid truncation. Thereby the mechanism of action of
SCRT is related to the activation of the extrinsic as
well as the intrinsic apoptosis pathways, amplifying
mitochondrial signaling. In addition, co-treatment of
LY294002, a PI3K inhibitor, significantly increased
SCRT-induced-apoptosis indicating that the PI3K/
AKT pathway might have a survival role in SCRT-
induced A549 cell apoptosis. To explore this rule, the
pathway must be blocked while the cells are treated
with SCRT. Although in vivo anti-cancer activity and
deep molecular mechanisms need further investiga-
tion, based on the results of this study, we believe
SCRT should continue to be developed as a possible
new therapeutic treatment for NSCLC.Competing interests
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